Checkpoint Inhibitors as High-Grade Gliomas Treatment: State of the Art and Future Perspectives.

Patients with low baseline levels of circulating CD4+ T cells and B cells (<0.40 × 10 6 cells/ mL and <0.19 × 10 6 cells/mL, respectively) showed a trend toward reduced PFS and OS [ 33 ].

also in 53,322 other papers